Gene · 6249
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy. | Vaccines (Basel) | 2022 | 36560459 | PubTator, text mining | PubMed |
| miRBind: A Deep Learning Method for miRNA Binding Classification. | Genes (Basel) | 2022 | 36553590 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| A novel approach for a joint analysis of isomiR and mRNA expression data reveals features of isomiR targeting in breast cancer. | Front Genet | 2022 | 36531236 | PubTator, text mining | PubMed |
| Genome wide CRISPR screen for Pasteurella multocida toxin (PMT) binding proteins reveals LDL Receptor Related Protein 1 (LRP1) as crucial cellular receptor. | PLoS Pathog | 2022 | 36516199 | PubTator, text mining | PubMed |
| Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma. | Front Cell Dev Biol | 2022 | 36506094 | PubTator, text mining | PubMed |
| The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction. | Front Cell Dev Biol | 2022 | 36506089 | PubTator, text mining | PubMed |
| MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B. | Int J Mol Sci | 2022 | 36499729 | PubTator, text mining | PubMed |
| Choosing the Probe for Single-Molecule Fluorescence Microscopy. | Int J Mol Sci | 2022 | 36499276 | PubTator, text mining | PubMed |
| Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR". | Int J Mol Sci | 2022 | 36498890 | PubTator, text mining | PubMed |
| Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers. | Cells | 2022 | 36497170 | PubTator, text mining | PubMed |
| Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A. | Nat Commun | 2022 | 36477027 | PubTator, text mining | PubMed |
| Transplantation of chemically-induced liver progenitor cells ameliorates hepatic fibrosis in mice with diet-induced nonalcoholic steatohepatitis. | Regen Ther | 2022 | 36475025 | PubTator, text mining | PubMed |
| Partial response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: a case report. | World J Surg Oncol | 2022 | 36471407 | PubTator, text mining | PubMed |
| Characterization and Spatial Mapping of the Human Gut Metasecretome. | mSystems | 2022 | 36468852 | PubTator, text mining | PubMed |
| Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report. | Medicine (Baltimore) | 2022 | 36451418 | PubTator, text mining | PubMed |
| Gene activation guided by nascent RNA-bound transcription factors. | Nat Commun | 2022 | 36443367 | PubTator, text mining | PubMed |
| Human T cells recognize HLA-DP-bound peptides in two orientations. | Proc Natl Acad Sci U S A | 2022 | 36442096 | PubTator, text mining | PubMed |
| SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7. | Front Immunol | 2022 | 36439103 | PubTator, text mining | PubMed |
| Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus. | Sci Rep | 2022 | 36434110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6249/papers?page=17